| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $868.5M | +21.5% |
| Cost of Revenue | $198.3M | +26.5% |
| Gross Profit | $670.1M | +20.1% |
| R&D Expense | $189.6M | +30.0% |
| SG&A Expense | $152.5M | +38.2% |
| Operating Income | $208.5M | +9.2% |
| Interest Expense | $14.6M | -16.3% |
| Pre-tax Income | $215.1M | +12.1% |
| Income Tax | $56.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $752.5M | +66.1% |
| Short-term Investments | $22.8M | +61.0% |
| Accounts Receivable | $96.8M | +16.6% |
| Inventory | $5.4M | -25.6% |
| Current Assets | $907.0M | +56.6% |
| Total Assets | $1.27B | +27.3% |
| Current Liabilities | $252.1M | +44.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $348.2M | +58.4% |
| Capital Expenditures | $310K | -73.1% |
| Investing Cash Flow | -$39.6M | +41.2% |
| Financing Cash Flow | -$9.0M | +17.7% |
| Free Cash Flow | $347.9M | +59.1% |
| +21.7% |
| Net Income | $158.7M | +9.1% |
| EPS (Basic) | $2.76 | +7.8% |
| EPS (Diluted) | $2.71 | +8.0% |
| Long-term Debt |
| $163.7M |
| -8.7% |
| Total Liabilities | $401.4M | +18.0% |
| Stockholders' Equity | $870.2M | +32.0% |